Literature DB >> 10377346

Mutant presenilin-1 induces apoptosis and downregulates Akt/PKB.

C C Weihl1, G D Ghadge, S G Kennedy, N Hay, R J Miller, R P Roos.   

Abstract

Most early onset cases of familial Alzheimer's disease (AD) are caused by mutations in presenilin-1 (PS1) and presenilin-2 (PS2). These mutations lead to increased beta-amyloid formation and may induce apoptosis in some model systems. Using primary cultured hippocampal neurons (HNs) and rat pheochromocytoma (PC12) cells transiently transfected with replication-defective recombinant adenoviral vectors expressing wild-type or mutant PS1, we demonstrate that mutant PS1s induce apoptosis, downregulate the survival factor Akt/PKB, and affect several Akt/PKB downstream targets, including glycogen synthase kinase-3beta and beta-catenin. Expression of a constitutively active Akt/PKB rescues HNs from mutant PS1-induced neuronal cell death, suggesting a potential therapeutic target for AD. Downregulation of Akt/PKB may be a mechanism by which mutant PS1 induces apoptosis and may play a role in the pathogenesis of familial AD.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10377346      PMCID: PMC6782321     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  39 in total

1.  Presenilins are processed by caspase-type proteases.

Authors:  H Loetscher; U Deuschle; M Brockhaus; D Reinhardt; P Nelboeck; J Mous; J Grünberg; C Haass; H Jacobsen
Journal:  J Biol Chem       Date:  1997-08-15       Impact factor: 5.157

2.  Direct association of presenilin-1 with beta-catenin.

Authors:  M Murayama; S Tanaka; J Palacino; O Murayama; T Honda; X Sun; K Yasutake; N Nihonmatsu; B Wolozin; A Takashima
Journal:  FEBS Lett       Date:  1998-08-14       Impact factor: 4.124

3.  Light and electron microscopic localization of presenilin-1 in primate brain.

Authors:  J J Lah; C J Heilman; N R Nash; H D Rees; H Yi; S E Counts; A I Levey
Journal:  J Neurosci       Date:  1997-03-15       Impact factor: 6.167

4.  Assessment of normal and mutant human presenilin function in Caenorhabditis elegans.

Authors:  D Levitan; T G Doyle; D Brousseau; M K Lee; G Thinakaran; H H Slunt; S S Sisodia; I Greenwald
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

5.  Phosphorylation and activation of p70s6k by PDK1.

Authors:  N Pullen; P B Dennis; M Andjelkovic; A Dufner; S C Kozma; B A Hemmings; G Thomas
Journal:  Science       Date:  1998-01-30       Impact factor: 47.728

Review 6.  Mechanism of activation and function of protein kinase B.

Authors:  D R Alessi; P Cohen
Journal:  Curr Opin Genet Dev       Date:  1998-02       Impact factor: 5.578

7.  Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation.

Authors:  B Wolozin; K Iwasaki; P Vito; J K Ganjei; E Lacanà; T Sunderland; B Zhao; J W Kusiak; W Wasco; L D'Adamio
Journal:  Science       Date:  1996-12-06       Impact factor: 47.728

8.  Expression and analysis of presenilin 1 in a human neuronal system: localization in cell bodies and dendrites.

Authors:  D G Cook; J C Sung; T E Golde; K M Felsenstein; B S Wojczyk; R E Tanzi; J Q Trojanowski; V M Lee; R W Doms
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

9.  Inhibition of Akt kinase by cell-permeable ceramide and its implications for ceramide-induced apoptosis.

Authors:  H Zhou; S A Summers; M J Birnbaum; R N Pittman
Journal:  J Biol Chem       Date:  1998-06-26       Impact factor: 5.157

10.  The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains beta-catenin.

Authors:  G Yu; F Chen; G Levesque; M Nishimura; D M Zhang; L Levesque; E Rogaeva; D Xu; Y Liang; M Duthie; P H St George-Hyslop; P E Fraser
Journal:  J Biol Chem       Date:  1998-06-26       Impact factor: 5.157

View more
  37 in total

1.  A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Abeta.

Authors:  Y Hashimoto; T Niikura; H Tajima; T Yasukawa; H Sudo; Y Ito; Y Kita; M Kawasumi; K Kouyama; M Doyu; G Sobue; T Koide; S Tsuji; J Lang; K Kurokawa; I Nishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

2.  The utility of muscarinic agonists in the treatment of Alzheimer's disease.

Authors:  William S Messer
Journal:  J Mol Neurosci       Date:  2002 Aug-Oct       Impact factor: 3.444

3.  Functional genomic analyses identify pathways dysregulated by progranulin deficiency, implicating Wnt signaling.

Authors:  Ezra Y Rosen; Eric M Wexler; Revital Versano; Giovanni Coppola; Fuying Gao; Kellen D Winden; Michael C Oldham; Lauren Herl Martens; Ping Zhou; Robert V Farese; Daniel H Geschwind
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

Review 4.  Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics.

Authors:  Richard S Jope; Christopher J Yuskaitis; Eléonore Beurel
Journal:  Neurochem Res       Date:  2006-08-30       Impact factor: 3.996

5.  Presenilins regulate the cellular level of the tumor suppressor PTEN.

Authors:  Han Zhang; Runzhong Liu; Ruishan Wang; Shuigen Hong; Huaxi Xu; Yun-wu Zhang
Journal:  Neurobiol Aging       Date:  2007-01-12       Impact factor: 4.673

6.  Impairments in fast axonal transport and motor neuron deficits in transgenic mice expressing familial Alzheimer's disease-linked mutant presenilin 1.

Authors:  Orly Lazarov; Gerardo A Morfini; Gustavo Pigino; Archana Gadadhar; Xiangjun Chen; John Robinson; Hanson Ho; Scott T Brady; Sangram S Sisodia
Journal:  J Neurosci       Date:  2007-06-27       Impact factor: 6.167

7.  Impaired neurogenesis is an early event in the etiology of familial Alzheimer's disease in transgenic mice.

Authors:  Michael Demars; Yuan-Shih Hu; Archana Gadadhar; Orly Lazarov
Journal:  J Neurosci Res       Date:  2010-08-01       Impact factor: 4.164

Review 8.  The molecular programme of tumour reversion: the steps beyond malignant transformation.

Authors:  Adam Telerman; Robert Amson
Journal:  Nat Rev Cancer       Date:  2009-01-30       Impact factor: 60.716

9.  Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.

Authors:  Martín Gómez Ravetti; Osvaldo A Rosso; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

10.  Presenilin-1 regulates induction of hypoxia inducible factor-1α: altered activation by a mutation associated with familial Alzheimer's disease.

Authors:  Rita De Gasperi; Miguel A Gama Sosa; Stella Dracheva; Gregory A Elder
Journal:  Mol Neurodegener       Date:  2010-09-23       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.